Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P23945: Variant p.Ile545Thr

Follicle-stimulating hormone receptor
Gene: FSHR
Feedback?
Variant information Variant position: help 545 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Isoleucine (I) to Threonine (T) at position 545 (I545T, p.Ile545Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (I) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In OHSS; displays promiscuous activation by both hCG and TSH together with detectable constitutive activity. Any additional useful information about the variant.


Sequence information Variant position: help 545 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 695 The length of the canonical sequence.
Location on the sequence: help PLSQLYVMSLLVLNVLAFVV I CGCYIHIYLTVRNPNIVSSS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         PLSQLYVMSLLVLNVLAFVVICGCYIHIYLTVRNPNIVSSS

Mouse                         PLSQLYVMALLVLNALAFVVICGCYTHIYLTVRNPNIVSSS

Rat                           PLSQLYVMALLVLNVLAFVVICGCYTHIYLTVRNPTIVSSS

Pig                           PLSQLYVVSLLVLNVLAFVVICGCYTHIYLTVRNPNIMSSS

Bovine                        PLSQLYVMSLLVLNVLAFVVICGCYTHIYLTVRNPNITSSS

Sheep                         PLSQLYVMSLLVLNVLAFVVICGCYTHIYLTVRNPNITSSS

Cat                           PLSQLYVMSLLVLNVLAFVVICCCYAHIYLTVRNPNIVSSS

Horse                         PLSQLYVMSLLVLNVLAFVVICGCYIHIYLTVRNPNIVSSS

Chicken                       PFSQAYVIFLLVLNVLAFVIICICYICIYFTVRNPNVISSN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 18 – 695 Follicle-stimulating hormone receptor
Transmembrane 529 – 550 Helical; Name=5
Helix 525 – 556



Literature citations
Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.
De Leener A.; Montanelli L.; Van Durme J.; Chae H.; Smits G.; Vassart G.; Costagliola S.;
J. Clin. Endocrinol. Metab. 91:555-562(2006)
Cited for: VARIANT OHSS THR-545; CHARACTERIZATION OF VARIANT OHSS THR-545;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.